T 1577/11 (Estrogen synthesis inhibitor anastrozole in early breast cancer/ … of 3.6.2015

European Case Law Identifier: ECLI:EP:BA:2015:T157711.20150603
Date of decision: 03 June 2015
Case number: T 1577/11
Application number: 02783305.2
IPC class: A61K 31/4196
A61P 35/00
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 441 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: USE OF ANASTROZOLE FOR THE TREATMENT OF POST-MENOPAUSAL WOMEN HAVING EARLY BREAST CANCER
Applicant name: AstraZeneca AB
Opponent name: Hexal AG
Alfred E. Tiefenbacher GmbH & Co. KG
STADA Arzneimittel AG
Helm AG
Teva Pharmaceutical Industries Ltd.
Board: 3.3.01
Headnote: -
Relevant legal provisions:
European Patent Convention Art 56
Rules of procedure of the Boards of Appeal Art 13
Keywords: Inventive step - reasonable expectation of success (yes)
Late-filed auxiliary request - admitted (no)
Catchwords:

-

Cited decisions:
G 0002/08
T 0918/01
Citing decisions:
-

5 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Offical Journal of the EPO

Case Law Book: I Patentability

Case Law of the Enlarged Board

General Case Law